Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Susan N. McLaughlin in Medical Treatments
Introduction
Susan N. McLaughlin, an accomplished inventor based in Phoenixville, PA, has made significant strides in the field of medical treatments through her innovative inventions. With two patents to her name, she demonstrates a commitment to improving health outcomes for patients suffering from various inflammatory conditions.
Latest Patents
McLaughlin's latest patents involve groundbreaking methods in treating leukocyte infections and modulating the function of monocytes. The first patent details a method of treating infections of mononuclear blood cells, excluding retroviral infections, through a process known as extracorporeal photopheresis. This technique employs a photoactivatable compound, which, when activated by ultraviolet light, enhances the therapeutic potential of the treatment. The second patent focuses on addressing inflammatory disorders of the bowel and urinary bladder, utilizing the same innovative approach of blood treatment and ultraviolet activation.
Career Highlights
Susan McLaughlin is currently associated with Therakos, Inc., a company committed to advancing medical therapies. Her career is marked by her dedication to research and development, targeting complex health issues with her inventive insights and methodologies.
Collaborations
Throughout her career, McLaughlin has worked alongside esteemed colleagues such as Bruce C. Stouch and Jerome B. Zeldis. Their collaborative efforts have contributed to the advancement of effective treatment modalities, furthering the impact of their innovations in the medical field.
Conclusion
In summary, Susan N. McLaughlin stands out as a prominent inventor whose contributions have a tangible impact on healthcare. Her patents not only reflect her ingenuity but also pave the way for new treatment options for patients facing challenging medical conditions. As she continues her journey at Therakos, her work is poised to revolutionize patient care and set new standards in medical treatment innovations.